Diagnostic Accuracy of the Oncuria-Detect Multiplex Immunoassay in Detecting Upper Tract Urothelial Carcinoma

Genitourinary Cancer

Predictors and patterns of non-urothelial recurrence after nephroureterectomy for upper tract urothelial carcinoma (UCAN Collaboration)

J Urol

Katims AB, Tin AL, Assel M, Hensley P, Li R, Margulis V, Matin S, Pallauf M, Clark RK, Raman JD, Singla N, Spiess PE, Coleman J

doi: 10.1097/JU.0000000000004646

Gastrointestinal Cancer

Clinical performance of tumor-informed versus tumor-agnostic ctDNA assays for colorectal cancer recurrence: A systematic review and diagnostic accuracy meta-analysis

Cancer Treat Rev

Camblor DG, Martínez-Castedo B, Martín-Arana J, Gimeno-Valiente F, García-Micó B, Martínez-Picó F, Seguí V, García-Bartolomé M, González D, Guimera A, Huerta M, Roselló S, Gambardella V, Roda D, Pappas L, Parikh A, Carbonell-Asins JA, Cervantes A, Tarazona N

doi: 10.1016/j.ctrv.2025.103066

Genitourinary Cancer

IP8-FLUORESCE: A Prospective Paired Cohort Study Evaluating the Diagnostic Accuracy of Fluorescence Confocal Microscopy for Real-time Assessment of Surgical Margins in Radical Prostatectomy

Eur Urol

Mayor N, Light A, Silvanto A, Haider A, Cullen E, Ng C, Boaz RJ, Gopalakrishnan A, Khoubehi B, Hellawell G, Almeida-Magana R, Mendes L, Dinneen E, Shaw G, Challacombe B, Cathcart P, Connor MJ, Shah TT, Ahmed HU, Fiorentino F, Winkler M

doi: 10.1016/j.eururo.2025.09.4171

Genitourinary Cancer

Diagnostic accuracy and outcomes of lymph node staging in intermediate-risk prostate cancer

BJU Int

Kniep C, Maurer T, Hartwieg BF, Mandel P, Wenzel M, Falkenbach F, Krpina K, Budäus L, Haese A, Salomon G, Steuber T, Graefen M, Tilki D, Preisser F

doi: 10.1111/bju.70155

Genitourinary Cancer

Adjuvant nivolumab versus placebo for high-risk muscle-invasive urothelial carcinoma: 5-year efficacy and ctDNA results from CheckMate 274

Ann Oncol

Galsky MD, Gschwend JE, Milowsky MI, Schenker M, Valderrama BP, Tomita Y, Bamias A, Lebret T, Shariat SF, Park SH, Agerbaek M, Jha G, Stenner F, Ye D, Giudici F, Connors J, Gupta S, Chhibber A, Zhang J, Bajorin DF, Witjes JA

doi: 10.1016/j.annonc.2025.09.139

Lymphoma

PET scan for the detection of histological transformation of follicular lymphoma: A systematic review of diagnostic performance

Blood Rev

Sorigue M, Miljkovic M, Mozas P

doi: 10.1016/j.blre.2025.101270

Genitourinary Cancer

Enfortumab vedotin plus pembrolizumab in treatment-naïve metastatic urothelial carcinoma patients: An Austrian real-world analysis

Int J Cancer

Niedersuess-Beke D, Mayrhofer K, Krauter J, Franke J, Vais D, Pallauf M, Kiesl D, Luger F, Pfuner J, Terbuch A, Bauernhofer T, Spielgelberg J, Banner A, Aufderklamm S, Wiesinger C, Schnabel S, Gampenrieder SP, Mühlmann J, Vallet S, Weibrecht S, Stoiber F, Andalibi H, Fajkovic H, Taghizadeh H, Miechowiecki J, Taedcke R, Heintel D, Shariat SF, Pichler M, Hilbe W, Pichler R

doi: 10.1002/ijc.70203

Genitourinary Cancer

Avelumab First-line Maintenance for Advanced Urothelial Carcinoma: Long-term Outcomes from the JAVELIN Bladder 100 Trial in Patients with Nonvisceral or Lymph Node-only Disease

Eur Urol

Bellmunt J, Powles T, Park SH, Voog E, Valderrama BP, Gurney H, Ullén A, Loriot Y, Sridhar SS, Tsuchiya N, Sternberg CN, Aragon-Ching JB, Petrylak DP, Climent Duran MA, Tyroller K, Hoffman J, Jacob N, Grivas P, Gupta S

doi: 10.1016/j.eururo.2025.05.017

Genitourinary Cancer

Characterization of Patients with Lymph Node Only Metastatic Urothelial Carcinoma Treated with Nivolumab Plus Gemcitabine-Cisplatin Versus Gemcitabine-Cisplatin Alone from the CheckMate 901 Trial

Eur Urol

Galsky MD, van der Heijden MS, Powles T, Claps M, Burotto M, Schenker M, Sade JP, Bamias A, Beuzeboc P, Bedke J, Oldenburg J, Ürün Y, Ye D, Valderrama BP, Tomita Y, Jiang R, Filian J, Wang L, van Kooten Losio M, Sonpavde G

doi: 10.1016/j.eururo.2025.04.019

Related content

Predictors and patterns of non-urothelial recurrence after nephroureterectomy for upper tract urothelial carcinoma (UCAN Collaboration)

Clinical performance of tumor-informed versus tumor-agnostic ctDNA assays for colorectal cancer recurrence: A systematic review and diagnostic accuracy meta-analysis

IP8-FLUORESCE: A Prospective Paired Cohort Study Evaluating the Diagnostic Accuracy of Fluorescence Confocal Microscopy for Real-time Assessment of Surgical Margins in Radical Prostatectomy

Diagnostic accuracy and outcomes of lymph node staging in intermediate-risk prostate cancer

Adjuvant nivolumab versus placebo for high-risk muscle-invasive urothelial carcinoma: 5-year efficacy and ctDNA results from CheckMate 274

PET scan for the detection of histological transformation of follicular lymphoma: A systematic review of diagnostic performance

Enfortumab vedotin plus pembrolizumab in treatment-naïve metastatic urothelial carcinoma patients: An Austrian real-world analysis

Avelumab First-line Maintenance for Advanced Urothelial Carcinoma: Long-term Outcomes from the JAVELIN Bladder 100 Trial in Patients with Nonvisceral or Lymph Node-only Disease

Characterization of Patients with Lymph Node Only Metastatic Urothelial Carcinoma Treated with Nivolumab Plus Gemcitabine-Cisplatin Versus Gemcitabine-Cisplatin Alone from the CheckMate 901 Trial